Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-12

Clinical Trial Update: Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease

View source ↗

Summary

A completed clinical trial assessing whether Type 2 diabetes mellitus acts as a catalyst for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Alzheimer´s Disease, Diabetes Mellitus Type 2 | Status: COMPLETED